UBS Downgrades Legend Biotech Corp. (LEGN) to Neutral

July 24, 2026 4:30 AM

UBS analyst Ashwani Verma downgraded Legend Biotech Corp. (NASDAQ: LEGN) from Buy to Neutral with a price target of $28.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found